Startup, Biotech, Entrepreneurship, Startup Funding, Fundraising For Startups.
patient population and improving treatment outcomes. The job of Theralia is to design a specific oligonucleotide that can target in a very sensitive and specific manner. “We are focusing on Staphylococcus aureus as a proof of concept and the market for Staphylococcus aureus, right now is around $4